Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tang, P.-Z.
Right arrow Articles by Dufau, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, P.-Z.
Right arrow Articles by Dufau, M. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 53, 37932-37940, December 31, 1999


A Novel Gonadotropin-regulated Testicular RNA Helicase
A NEW MEMBER OF THE DEAD-BOX FAMILY*

Pei-Zhong Tang, Chon-Hwa Tsai-Morris, and Maria L. DufauDagger

From the Section of Molecular Endocrinology, Endocrinology and Reproduction Research Branch, NICHHD, National Institutes of Health, Bethesda, Maryland 20892

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A gonadotropin-regulated testicular RNA helicase (GRTH) was identified and characterized. GRTH cloned from rat Leydig cell, mouse testis, and human testis cDNA libraries is a novel member of the DEAD-box protein family. GRTH is transcriptionally up-regulated by chorionic gonadotropin via cyclic AMP-induced androgen formation in the Leydig cell. It has ATPase and RNA helicase activities and increases translation in vitro. This helicase is highly expressed in rat, mouse, and human testes and weakly expressed in the pituitary and hypothalamus. GRTH is produced in both somatic (Leydig cells) and germinal (meiotic spermatocytes and round haploid spermatids) cells and is developmentally regulated. GRTH predominantly localized in the cytoplasm may function as a translational activator. This novel helicase could be relevant to the control of steroidogenesis and the paracrine regulation of androgen-dependent spermatogenesis in the testis.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The closely related gonadotropins, luteinizing hormone (LH)1 and human chorionic gonadotropin (hCG), exert their functions through specific G protein-coupled receptors in gonadal cells. Physiological concentrations of gonadotropins maintain the steroidogenic function of the Leydig cells of the testis (see Ref. 1 for review). However, high concentrations of gonadotropins cause desensitization of steroidogenic enzymes of the androgen pathway, with consequent reduction of testosterone formation (2-5). The attenuation of steroidogenesis results from receptor activation by the gonadotropic hormone but is independent of the subsequent phase of receptor down-regulation. The control of the enzymes involved in this regulation including 3beta -hydroxysteroid dehydrogenase types I and II (3), 17alpha -hydroxylase/17, 20 lyase (5), and 17beta -hydroxysteroid dehydrogenase type III (4) operates at the transcriptional level. Because this process affects several enzymes, the direct or indirect involvement of a master switch has been proposed (3). Likely candidates for this regulation include the active steroid metabolites that are produced during gonadotropic stimulation, i.e. androgen (3) and estrogen (6-8).

To identify potentially relevant proteins that participate in gonadotropin up- or down-regulation of steroidogenic enzymes at the transcriptional or post-transcriptional level, we utilized differential display analysis of RNA from testicular Leydig cells subjected to a single exposure of gonadotropin in vivo. We report the demonstration of a novel gonadotropin-regulated testicular RNA helicase (GRTH) that belongs to the family of DEAD-box proteins and is predominantly expressed in Leydig and germinal meiotic cells of the testis. This protein was found to be markedly up-regulated in the Leydig cell by hCG doses that cause steroidogenic desensitization. It is likely that GRTH serves in general to maintain receptors, enzymes, and factors that support testicular functions and spermatogenesis.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Animal Treatment and Cell Preparation-- Gonadotropin-induced LH receptor and steroidogenic enzymes down-regulation of Leydig cells was produced as described previously (2) by administration of a single 2.5-µg subcutaneous injection of hCG (Pregnyl, Organon) to adult male rats (200-250 g) (Charles River Laboratories Inc., Wilmington, MA). Animals were sacrificed 24 h after hCG treatment, and testes were removed. Leydig cells were prepared by collagenase dispersion and purified by centrifugal elutriation as described previously (9). The cells were frozen at -70 °C until the further extraction of RNA. Following collagenase dispersion to obtain Leydig cells, the seminiferous tubules were further treated with collagenase (0.05%) until no interstitial cells remained adhered to the tubules as assessed under inverted microscope. Tubules were minced into 1-2-mm segments, resuspended in Medium 199, 0.1% BSA, and shaken (120 rpm/min) for 20 min at 37 °C. The fragments were allowed to settled for 5 min, and germ cells were collected from supernatant by centrifugation.

In Vitro Study of the Hormonal Regulation of GRTH Leydig Cells in Primary Culture-- Leydig cells were plated (1 × 106 cells/ml) for 1 h and incubated with hCG or 8-bromo-cAMP or buffer (control) for 20 h. In studies conducted to examine the effects of endogenous or exogenous steroids, cells were preincubated with or without inhibitors of steroid biosynthesis (aminoglutethimide, 100 µg/ml; cyanoketone, 1 µM, and spironolactone, 10 µM (Sigma) for 20 min at 34 °C and kept throughout the culture. The cells were then incubated with hormones for 20 h. These compounds were previously found to inhibit effectively the enzymes of the steroidogenic pathway in the Leydig cells and consequently inhibited testosterone production (9-12). The enzymes blocked by the inhibitors included cholesterol side chain cleavage and aromatase (aminoglutethimide), 3beta -hydroxysteroid oxidoreductase Delta -5 isomerase (cyanoketone), and 17alpha -hydroxylase/17-20 desmolase (spironolactone). Total RNA was isolated from Leydig cells using TRIzol RNA reagent (Life Technologies, Inc.). Levels of GRTH mRNA were analyzed by Northern blot.

Differential Display Analysis-- Three sets of total RNA samples (300 ng for each) independently prepared from Leydig cells of rats treated with and without hCG were analyzed by differential display essentially as described previously (13). Briefly, samples were reversed-transcribed using six downstream primers followed by PCR with the same downstream primer and 12 different upstream primers (random 10-mers). PCR products with incorporated [33P]dATP (2000 Ci/mmol, NEN Life Science Products) were separated in non-denatured 6% sequencing gels. Gels were dried and evaluated by autoradiography. Regions containing differential bands on the gel were excised and eluted by electrophoresis. The products were reamplified and resolved by single strand conformation polymorphism gels to confirm that a single differential fragment was contained in each excised band. The differential bands were eluted, reamplified by PCR, separated on a 1.5% agarose gel, and eluted by electrophoresis. The differential fragments were cloned and sequenced. The nucleotide sequences were compared with sequences in the GenBankTM/EMBL data bases using FASTA program. The individual bands were verified by RNA protection analysis.

RNase Protection Assay-- RNase protection assays were performed by established methodology (14). The GRTH cRNA probe was generated by PCR followed by subcloning and in vitro transcription. Primers were used to amplify a fragment complementary to the coding region (256-611 nt position), see Fig. 1. Also, primers located at exons 4 and 5 of the rat beta -actin gene were employed to amplify the beta -actin fragment (270 bp) used as control. The constructs were linearized and used as template for the in vitro transcription with RNA polymerase T7 (Life Technologies, Inc.) and labeled with [32P]UTP (800 Ci/mmol, ICN Biomed). 10 µg of total RNA samples were applied for hybridization. Ribonuclease T1 and ribonuclease A (Life Technologies, Inc.) were used for the digestion of unhybridized RNA and cRNA probe. The protected fragments were resolved on 6% sequencing gels and quantified by PhosphorImager analysis.

Isolation and Cloning of Rat Leydig Cell and Mouse and Human Testis GRTH cDNA-- The PCR fragment derived from differential display analysis was labeled with [32P]dCTP and used as probe for screening of a rat Leydig cell cDNA library in ZAP ExpressTM vector (Stratagene, La Jolla, CA). Superscript mouse and human testis cDNA libraries (Life Technologies, Inc.) were screened with [32P]dCTP-labeled PCR fragments 256-601 and 475-1065 (nt positions) of rat GRTH. Positive clones for each screened library were isolated and sequenced.

Chromosomal Localization-- Chromosomal mapping (rat, mouse, and human) was performed using fluorescence in situ hybridization (FISH) signal mapping and 4',6-diamidino-2-phenylindole stain to assign chromosome number (see DNA Biotech Inc. Windsor, Canada). GRTH cDNA probe of 1.6 kb (rat, mouse, and human) was biotinylated with dATP using the Life Technologies, Inc., BioNick labeling kit (15 °C for 1 h) (15) and used for hybridization (16 h) of denatured chromosomal slides. Under the conditions used, FISH detection efficiencies were 68% (human), 61% (mouse), and 71% (rat) for this probe among 100 mitotic figures checked.

Northern Blot, mRNA Stability, and Nuclear Run-off Assay-- mRNA was extracted from rat Leydig cells and from various male and female rat tissues using Fast-Track mRNA isolation kits (Invitrogen, Carlsbad, CA). The mRNA samples (5 µg) were resolved on 1% agarose gels, transferred onto a GeneScreen membrane (Biotechnology System, NEN Life Science Products), and hybridized with 32P-labeled rat GRTH cDNA probe (1.6 kb) at 50 °C overnight. To investigate the stability of the GRTH mRNA, cells were incubated with 10 µg/ml actinomycin D for 0-10 h in medium 199, 0.1% BSA. 10-µg mRNA samples were resolved as described above. Hybridization was quantified by PhosphorImager analysis. Nuclear run-off assays were performed as described previously (3, 16).

Transient Cotransfection Analyses of GRTH cDNA with Different Promoter-Luciferase Constructs-- GRTH cDNA (1 µg) inserted in plasmid pBK (pBK-GRTH) or plasmid only (pBK) as a control was transiently cotransfected into mLTC cells with different gene core promoters constructed in pGL plasmid (2 µg), anchored with luciferase cDNA as a reporter gene using Cytofectin GS-3815 (Glen Research, Sterling, VA). Luciferase activity and mRNA were quantitated.

In Situ Hybridization Analysis of GRTH mRNA in Rat Testis-- In situ hybridization was carried out following standard protocols (17). Briefly, testes from prepubertal, pubertal, and adult animals were fixed in 4% paraformaldehyde for 16 h at 22 °C. Slides were hybridized to 35S-labeled GRTH cRNA probes (sense and antisense) for 16 h at 45 °C. The probes were synthesized by in vitro transcription using a Maxiscript kit (Ambion Inc, TX) and 35S-UTP (1250 Ci/mmol). Following the hybridization procedure, slides were coated with K5 emulsion (Ilford, UK) and exposed for at least 4 days. Slides counterstained with hematoxylin-eosin were photographed using bright- and dark-field optics and polarized epi-illumination. For preparation of purified Leydig cells a plasma clot of the cells was prepared and processed.

Subcellular Localization of Rat GRTH in mLTC Cells Using Living Colors GFP System and Confocal Microscopy-- The full length of GRTH cDNA coding region was subcloned into the pEGFP-N3 vector (GRTH-EGFP). The cDNAs of GRTH-EGFP (2 µg/ml) or pEGFP vector only (2 µg/ml) were transfected into mLTC cells using Cytofectin GS-3815. After 24 h of incubation the cells were examined in an inverted microscope under a 40× oil-immersion objective (Nikon, Inc., Melville, NY) and a Bio-Rad laser confocal microscope system (MRC-1024). Also the mLTC cells transfected with and without GRTH-EGFP or EGFP were harvested for Western blot analyses using GFP monoclonal antibody (CLONTECH).

In Vitro Transcription/Translation of GRTH cDNA-- The rat 1.6-kb GRTH cDNA (1 µg) cloned in the pBK-CMV vector containing a T3 promoter (pBK-GRTH) was in vitro transcribed and translated into protein using the T3-coupled Reticulocyte Lysate System (Promega, Madison, WI) following the manufacturer's protocol. The vector without insert (pBK) was used as negative control. [35S]methionine (Amersham Pharmacia Biotech) was added to the translation reaction, and the labeled translated protein samples were then resolved on 10% SDS-polyacrylamide gels.

In Vitro Translation Assays-- Luciferase RNA poly(A) template was generated by the in vitro transcription of the full-length luciferase cDNA cloned in the pSP64 poly(A) vector (Promega). In vitro translation assays were carried out in a 50-µl reaction with additions of purified recombinant GRTH-GST fusion protein or GST (250 and 500 ng), 20 µCi of [35S]methionine (1000 Ci/mmol, 10 mCi/ml, Amersham Pharmacia Biotech), 20 µM amino acid mixture lacking methionine, 40 units of ribonuclease inhibitor, 1 µg of luciferase RNA, and 25 µl of reticulocyte lysate treated with micrococcal nuclease containing 2.5-µg mixture of tRNAs, 1 µg of hemin, 4 mM potassium acetate, and ATP-regenerating system phosphocreatinine/phosphocreatinine kinase. Samples were incubated for 90 min at 30 °C. The 61-kDa radiolabeled luciferase translated protein was resolved on 10% SDS-polyacrylamide gel. Autoradiograms were quantitated by Imaging Densitometer model GS-700 (Bio-Rad) and expressed as percent of GST control.

Expression and Purification of Rat GRTH from Bacteria-- The GRTH cDNA was subcloned into pGEX-2T glutathione S-transferase (GST) gene vector (GRTH-GST). The construct was verified by sequence and transformed into Escherichia coli BL21. The MicroSpinTM GST Purification Module System (Amersham Pharmacia Biotech) was used for the purification of GRTH-GST fusion protein. The purified protein recovered from the columns was aliquoted and analyzed by SDS-PAGE and Western blot analyses.

Preparation of Helicase Substrates-- The long strand of RNA (5'-GGCCGAAUUGGGUACACUUACCUGGUACCCCACCCGGGUGGAAAAUCGAUGGGCCCGCGGCCGCUCUAGAAGUACUCUCGAGAAGCUUUUUGAAUU-3') was synthesized by in vitro transcription and purified by gel electrophoresis. The short strand of RNA (5'-GGCCCAUCGAUUUU-3') with 5'-hydroxyl terminus complementary to the middle region of the long strand of RNA was synthesized by Cruachem Inc. (Dulles, VA). All the DNA oligomers were synthesized by DNA synthesizer. The sequence of the long DNA oligomer corresponds to the long strand of RNA. The three short DNA oligomers (5'-TTCTAGAGCGGCCGCGGGCC-3'; 5'-TAAGTGTACCCAATTCGCCC-3'; and 5'-TTCAAAAAGCTTCTCGAGAG-3') correspond to the mid-region, 5'-end, and 3'-end of the long RNA strand, respectively. The short strands of RNA and DNA were labeled by 32P using T4 polymerase kinase (Life Technologies, Inc.) and [gamma -32P]ATP. Labeled short strands (15 pmol) were annealed to long strands (10 pmol) by gradually decreasing the temperature from 90 to 4 °C within 3 h in the buffer of 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 2 mM MgCl2, 1 mM EDTA. The annealed substrates were resolved on 4% agarose gels, eluted by electrophoresis, and precipitated by ethyl alcohol. The purified substrates were dissolved in the helicase assay buffer.

Helicase and ATPase Activity Assays-- The helicase assay was carried out in 15 µl of buffer (20 mM HEPES-KOH (pH 7.5), 50 mM KCl, 3 mM MgCl2) containing 0.1 mg/ml BSA, 1 unit/µl RNase inhibitor (Promega), 0.4 mM dithiothreitol, 1 mM ATP, 0.2 pmol double strand substrates, and different amounts (0.1 to 1.0 µg) of purified GRTH-GST or GST (control) proteins. The mixture was incubated for 30 min at 37 °C. Double-stranded substrates boiled for 3 min were used as positive controls. Aliquots (10 µl) of each reaction were separated by 8% native polyacrylamide gels and recorded by radioautography. The ATP hydrolysis activity was analyzed as described previously (18). 1.5 µg of purified GRTP-GST or GST (control) proteins and 0.3 A260 units of different RNAs (mRNA and total RNA from rat Leydig cell, tRNA from yeast, poly(A) and poly(U) from Life Technologies, Inc.) were used for each reaction.

All experiments were performed at least three times in triplicate. Statistical significance was evaluated by analysis of variance.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification, Isolation, and Cloning of a Novel Gonadotropin-regulated Testicular Gene GRTH-- To identify genes that are regulated by gonadotropin, we compared differential display patterns of RNA obtained from Leydig cells of rats treated with a single desensitizing dose of hCG (2.5 µg) or vehicle alone 24 h prior to sacrifice. Differential display PCR using 6 downstream and 12 upstream primers (see "Experimental Procedures") revealed 30 differential candidate bands that were observed in the three different RNA samples, of which 6 were up-regulated and 24 were down-regulated. After single-strand conformation polymorphism analysis, sequencing of the fragments, and RNA protection verification, one up-regulated fragment and six down-regulated fragments were obtained. PCR amplifications using primers 5'-dT11GA-3' and 5'-GATCATGGC-3' revealed a 84-bp fragment which appeared to be up-regulated by the hormone is shown in Fig. 1A, left. This 3' fragment displayed no similarity to any gene on the Data Bank. Subsequently, RNase protection assays using the 84-bp fragment and a 355-bp GRTH cDNA derived from the coding region (see below) confirmed that this gene was up-regulated by hCG (Fig. 1A, middle). The protected fragment of beta -actin mRNA (290 bp) used as an internal control in this study showed no change.


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 1.   A, up-regulation of GRTH by hCG identified by mRNA differential display analysis (left) and confirmed by RNase protection assay (middle) in rat Leydig cells and in vitro translation and mammalian expression (right). Differential display analysis of three sets of total RNA samples from Leydig cells of rats treated 24 h prior with a single dose of hCG (2.5 µg) (+) or vehicle alone (-). One PCR fragment (84 bp), indicated by arrows in the cDNA sequence below, was up-regulated by hCG treatment (left). Autoradiography of RNase protected fragments. Total RNA samples (10 µg) were hybridized to 32P-labeled cRNA GRTH probes: the 84-bp probe (differential display PCR product) and a 355-bp probe (+256 to +611 nt) from the GRTH coding region (shown by arrows with asterisks) simultaneously with a beta -actin fragment (290 bp) probe as internal control (middle). In vitro transcribed/translated GRTH and GRTH cDNA (GRTH-V5) expressed in mLTC cells was detected by V5 antibody (right). B, rat, mouse, and human GRTH cDNA nucleotide and deduced amino acid sequences of the rat encoded protein. The complete nucleotide sequence of the rat GRTH (1629 bp) is derived from screening a rat Leydig cell cDNA library. An open reading frame of 369 amino acids is shown below the nucleotide sequence. Differences of the human (h) and mouse (m) GRTH from the rat (r) sequence are indicated in lowercase letters above the rat sequence. The deduced amino acid rat, mouse, and human sequences of GRTH contain all conserved domains of DEAD-box family of RNA helicases (underlined).

To characterize the cDNA sequence of this hCG-regulated mRNA, the 32P-labeled 84-bp PCR fragment was used as a probe to screen a rat Leydig cell cDNA library. The full-length sequence (1629 bp) contained an open reading frame encoding 369 amino acids (Fig. 1B) (GenBankTM accession number AF142629). The in vitro transcribed/translated rat GRTH cDNA yielded a protein of 43 kDa (Fig. 1A, right), in agreement with the expected size from the deduced amino acid sequence of 369 amino acids (Fig. 1B). Furthermore, mLTC cells transfected by rat GRTH cDNA with a V5 tag expressed a protein of molecular size comparable to the in vitro translated GRTH protein (Fig. 1A, right). Also, the mouse and human GRTH cDNA sequences were isolated from mouse and human testis cDNA libraries. The nucleotide and deduced amino acid sequences of the mouse (GenBankTM accession number AF142630) displayed 96 and 99% similarity to the rat sequence, respectively, and those of the human sequences (GenBankTM accession number AF155140) were 86 and 95% similar to the rat.

A data base search using the FASTA program of GCG revealed similarity of the rat GRTH sequence to those members of the DEAD-box family of RNA helicase and contained the seven highly conserved signature regions of the family (Fig. 1B, underlined) including the (A/S)XXGXGKT and DEAD domains involved in ATP binding and/or ATP hydrolysis and SAT and HRIGRXXR domains involved in RNA binding and unwinding (19). A phylogram produced by the PILEUP program of the GCG package based on 116 members of the DEAD-box family indicated that GRTH is genetically close to mouse DEAD5, a protein of unknown function (70%, amino acid identity) (20) and yeast Dbp5p, required for poly(A) RNA export (49%) (21). It is less related to initiator factors (eIF4As) of the translation complex in several species (41-42%) (22), the human oncogene RCK homolog DDX6 (36%) (23), Drosophila Me31B required for oogenesis (37%) (24), and yeast Ste13 required during mating (37%) (25). GRTH is more distantly related to mouse PL10, a protein found in cells of the germinal epithelium (35%) (26), and human p68, a protein related to cell growth and division (32%) (27).

Chromosomal Localization of GRTH-- Chromosomal mapping using human, mouse, and rat lymphocytes revealed that this gene resides in chromosomes 11q24 (human), 8q21 (rat), and 9A3-A5 (mouse) (Fig. 2). A search of mouse to human homology region indicated that genes mapped in the region of mouse 9A3-A5 mostly corresponded to the region of human 11q22-24, including the potassium inwardly rectifying channel subfamily J members 5 (GIRK4), Friend leukemia virus integration 1 (FLIL) genes, and DDX6 genes (23).


View larger version (75K):
[in this window]
[in a new window]
 
Fig. 2.   Chromosome mapping of rat, mouse, and human GRTH gene. On the left are shown the FISH signals for each species. On the right are provided the corresponding mitotic figures stained with 4',6-diamidino-2-phenylindole for chromosomal identification and region assignment. In the diagrams each dot represents double FISH signals detected (detailed positions were determined based on data from 10 individual photographs).

Localization of GRTH by in Situ Hybridization-- Cellular localization of GRTH mRNA within the rat testicular compartments revealed that GRTH transcripts were present in both interstitial and germ cells of the adult testis (Fig. 3). Some of the interstitial cells showed strong signals and others were negative. Variations were observed among the individual interstitial spaces (Fig. 3, C and D). In highly purified Leydig cell preparations (95% purity) isolated from the interstitial compartment of the adult rat testis, 60% of the cells (from 500 cells counted) were positive (Fig. 3A). Since these animals had not received exogenous hormone treatment, these observations likely reflect the stimulation/maintenance of expression by endogenous gonadotropin/androgen. Prominent and dense labeling within the seminiferous tubules of adult rats was highest in cells in meiotic phase, predominantly in pachytene spermatocytes (Fig. 3I). GRTH mRNA was also present in round spermatids of the adult rat testis (Fig. 3K). Cells within the basal compartment, including spermatogonia and preleptotene spermatocytes, were clearly negative as were the Sertoli cells (Fig. 3J). In the pubertal testis, only cells in meiotic phase, mainly pachytene spermatocytes, were positive. Again basally located cells, including Sertoli cells, were negative (Fig. 3H). Developmental studies demonstrated that GRTH was not present in the testis of immature animals (8 and 12 days old, data not shown), but positive signals were present in tubules and Leydig cells of pubertal animals (23 and 26 days) and in the adult testis. Under low magnification (× 5), it was evident that at the pubertal stage some tubules were frankly positive, and others showed low positivity (indicated by the presence of a bright or pale ring, respectively, within the seminiferous tubule) (Fig. 3F). In contrast, in the adult testis all tubules were positive, with some gradations in grain density (not shown). These studies, and those presented in Fig. 4A, demonstrate that the expression of GRTH in the testis is developmentally regulated.


View larger version (71K):
[in this window]
[in a new window]
 
Fig. 3.   Cellular localization of GRTH in the rat testis by in situ hybridization. Detection of rat GRTH mRNA in isolated Leydig cells and tissue section by in situ hybridization, photographed by dark field (A, B, F, and G), bright (C and H), and epi-illumination/bright field microscopy (D, E, I, J, and K). A, 60% of purified rat Leydig cells are positive. B, Leydig cells incubated with sense probe are negative. C, some interstitial cells in adult testis that resemble Leydig cells are positive (black arrow), and others are negative (white arrow). D, several interstitial cells in the adult testis that resemble Leydig cells close to the blood vessel are positive. E, negative sense control for D. F, positive signal in germ cells within the seminiferous tubules of day 23 pubertal testis. G, negative, sense control for F. H, positive signal is noted only in germ cells at meiotic phase in pubertal testis, including pachytene spermatocytes. Basal cells including spermatogonia and Sertoli cells (arrowhead) are negative. I, an overexposed view to demonstrate mRNA expression in meiotic germ cells of adult testis but negative in spermatogonia and preleptotene spermatocytes at the periphery. J, positive signal is noted only in meiotic germ cells of adult testis. Arrowhead points to negative Sertoli cells. K, positive signals in both round spermatids (top tubule) and pachytene spermatocytes (bottom tubule) in adult testis. Bars = 25 µm.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 4.   A, Northern blot analysis of GRTH mRNA. mRNA samples isolated from several adult tissues of male rats and from ovaries of cycling (ovary) and pregnant (preg.) female rats; Leydig cells (L.C.) and germ cells (GC) obtained from adult rats treated with 2.5 µg of hCG (+) or control (-); adult rat, mouse, and human testes and tumor rat (R2C) and mouse (mLTC) Leydig cell lines; testes of different ages as follows: mouse, pre-pubertal (2 weeks), pubertal (4 weeks), and adult (8 weeks); rat, pre-pubertal (1 and 2 weeks), pubertal (3 and 4 weeks), and adult (6 and 8 weeks). Samples were hybridized with a rat GRTH cDNA probe (1.6 kb) and rehybridized with cDNA beta -actin probe. B, time course study of GRTH mRNA regulated by hCG. Leydig cells from male rats injected with 2.5 µg of hCG after 1-12 h treatment (short term) and 1-9 days (long term). RNase protection assays were performed for the short term study, and Northern blot analyses were performed for long term study. Data normalized by beta -actin are presented as percent mean ± S.E. relative to saline control. C, stability of GRTH mRNA (left) and nuclear run-off assay (right). Gonadotropin-desensitized Leydig cells were obtained 12 h after treatment from rats with a single dose of hCG (2.5 µg). Cells were incubated with 10 µg/ml actinomycin D for 0-10 h. The mRNA samples (10 µg) were analyzed by Northern blot (left). Nuclei prepared from control and hCG-desensitized Leydig cells in the presence of [32P]UTP were analyzed by nuclear run-off assay (right). The newly transcribed RNAs were hybridized to a nitrocellulose membrane on which cDNAs of GRTH (20 µg), beta -actin (20 µg), and vector (20 µg) have been immobilized. Results were recorded by autoradiography for visual display (upper) and quantified by PhosphorImager (lower). Data are percent of means ± S.E. relative to control.

Tissue and Cell Distribution of GRTH Transcripts-- The tissue distribution of the GRTH transcript studied by Northern blot analysis detected a single transcript of 1.6 kb. In Fig. 4A, it is shown that GRTH is predominantly expressed in the testis and less abundantly in the hypothalamus, pituitary, and brain but was not expressed in ovary or other tissues examined (Fig. 4A, left panel). GRTH mRNA was detected in Leydig cells (L.C.), and its abundance was comparable to that observed in germ cells (GC). In germinal cells, mRNA levels were very similar in both hCG-treated and untreated groups in contrast to the mRNA of Leydig cells from hCG-treated adult animals (+) which was significantly increased when compared with control. Northern blot analysis also detected a single transcript in adult normal human testis (Cooperative Human Tissue Network, Philadelphia, PA) and mouse testis (Fig. 4A, middle). However, GRTH mRNA was not expressed in mouse (mLTC) and rat (R2C) tumor Leydig cell lines, whereas beta -actin mRNA was present at similar levels in the samples. GRTH was abundantly expressed in the adult testis in both Leydig cells (interstitium) and germ cells (tubules). Developmental studies demonstrated that testicular GRTH mRNA levels were very low in 1-2-week immature animals (Fig. 4A, right). However, the mRNA levels were markedly increased (40-fold) during early puberty (weeks 3 and 4). After puberty, when the spermatogenic process is completely established, the GRTH mRNA levels in adult mouse and rat testes were not significantly increased over those observed in early pubertal or pubertal animals. This stage-specific expression of mRNA indicated that GRTH may play a role in spermatogenesis.

hCG-induced Up-regulation of GRTH mRNA in Rat Leydig Cell-- To gain insights into the characteristics of the regulatory mechanism(s) of hCG-mediated GRTH mRNA up-regulation and its correlation with the down-regulation of steroidogenic enzymes in the Leydig cell described in our previous studies, temporal studies were conducted following the administration of a desensitizing dose of hCG (2.5 µg). No significant changes in GRTH mRNA levels were observed at 1 and 4 h, whereas these were significantly increased at 12, 19, and 24 h (p < 0.01, p < 0.001, p < 0.001) and returned gradually to near-control and control levels at days 4 and 9 after hCG treatment, respectively (Fig. 4B).

Up-regulation of GRTH mRNA by hCG at Transcriptional Level-- To explore whether increases in GRTH mRNA induced by hCG were related to changes in mRNA stability, we assessed GRTH mRNA degradation rates. The mRNA levels at different times after treatment with actinomycin D were generally higher in the samples from hCG-treated animals than in controls (Fig. 4C). Only 20% of GRTH mRNA was degraded after 10 h of actinomycin D treatment in samples from both treated and non-treated groups which indicated that the half-life of GRTH mRNA in Leydig cells was very long. The degradation rates between the two groups were very similar. This indicated that up-regulation of GRTH mRNA in the Leydig cells was not due to stabilization of the mRNA by hCG but rather to a change in transcriptional activity. Nuclear run-off assays demonstrated that newly synthesized GRTH 32P-labeled Leydig cell mRNA from hCG-treated animals increased when compared with non-treated controls, whereas beta -actin (control) remained unchanged (Fig. 4C).

In Vitro Study of the Hormonal Regulation of GRTH in the Primary Cultures of Leydig Cells-- To elucidate further the mechanism of hCG-induced GRTH mRNA increase in Leydig cells, in vitro studies were performed in primary Leydig cell cultures. Both hCG and cAMP cause increases in GRTH mRNA levels by 35 and 41%, respectively (p < 0.01) (Fig. 5A). The increases of GRTH mRNA induced by hCG (Fig. 5B) or cAMP (not shown) were prevented by inhibitors of steroidogenic enzymes that abolished the stimulation of the formation of active androgens, estrogen, and their precursors (10). Dihydrotestosterone increased GRTH mRNA level by 40% in primary cultures of Leydig cells, in which the production of endogenous steroids had been blocked by the addition of inhibitors (Fig. 5B). In contrast, estradiol had no effect on GRTH expression. Thus, the fact that hCG was unable to stimulate GRTH expression when endogenous production of androgen action was blocked by the inhibitors of steroidogenic enzymes, coupled to the finding that dihydrotestosterone was able to elicit similar increases as hCG in these cells, strongly indicated that hCG-induced GRTH expression was mediated through the action of androgens in Leydig cells. GRTH levels in controls were due to the presence of endogenous androgens in the cells, and these were not changed in cultures where steroidogenesis was inhibited. This is expected since the incubation time of the primary culture was relatively short and the half-life of GRTH is long to reveal the impact of the reduced androgen levels.


View larger version (62K):
[in this window]
[in a new window]
 
Fig. 5.   Hormonal regulation of GRTH in primary Leydig cells cultures in vitro. A, Northern blot analysis of GRTH mRNA from Leydig cells treated with hCG (10 ng/ml) or 8-bromo-cAMP (1 mM) or phosphate-buffered saline (control) for 20 h. B, Leydig cells preincubated with or without the inhibitors of steroidogenic enzymes and androgen production for 20 min, followed by 20 h incubation with 50 nM estradiol (E2) or 100 nM dihydrotestosterone (DHT) or hCG. Results were quantified by PhosphorImager (counts were normalized by beta -actin). Data are presented as percent of means ± S.E. relative to control in A or the inhibitor (Inh.) alone in B.

Exploring the Function of GRTH-- To examine whether GRTH was involved in the regulation of Leydig cell steroidogenic enzymes and receptors, and to gain further insights into the cellular function of GRTH, we evaluated the changes induced by cotransfected GRTH (GRTH-pBK) on luciferase activity generated from constructs containing the luciferase reporter gene driven by promoters of relevant Leydig cell genes in mLTC cells (Fig. 6A, left). An increase of 50-80% in luciferase activity over controls (pBK) was observed with the four constructs bearing relevant promoters. This finding demonstrated that the hCG-induced down-regulation of the expression of these genes observed in our previous studies (3-5) was not related to the up-regulation of GRTH. The similar increase in activity with the four gene promoters indicated that the GRTH action was related to a general mechanism not concerned with the regulation of transcription. This was supported by the observation that a construct bearing a promoter of a gene not expressed in the Leydig cell (SV-40) was also stimulated by GRTH. In contrast, simultaneous quantitation of luciferase mRNA by RNase protection assay in mLTC cells cotransfected with GRTH cDNA (pBK-GRTH) revealed no changes when compared with cells cotransfected with pBK empty vector, lacking GRTH (Fig. 6A, right). This finding supports the notion that the increase of luciferase activity induced by GRTH was not due to transcriptional stimulation of the gene promoter but likely to changes at the translational level. In vitro translation studies demonstrated that recombinant GRTH-GST (250 and 500 ng) increased translation of luciferase RNA template over GST control by 100 and 200%, respectively (Fig. 6B). This further indicated the potential role of GRTH in translation.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 6.   A, left, cotransfection of pBK-GRTH or plasmid pBK with different gene core promoters/luciferase in mLTC cells. Luciferase activity was evaluated as indicative of luciferase protein expression. hLHR174 and r-LHR174, human and rat luteinizing hormone receptor promoters (36, 37); PRLR-P1, rat prolactin receptor promoter-1 (38); P450-17alpha , rat 17alpha -hydroxylase/17,20 lyase promoter (39); SV40, eukaryotic simian virus-40 promoter. Right, quantitation of luciferase mRNA by RNA protection assay. A portion of mLTC cells cotransfected with pBK-GRTH or pBK with r-LHR174/luciferase was used for luciferase mRNA quantitation. Data are presented as percent of means ± S.E. relative to pBK control. B, GRTH effect on in vitro translation. Data are expressed as percent increases of luciferase RNA translation induced by GRTH-GST over the GST control (250 and 500 ng of GRTH-GST or GST). C, subcellular localization of GRTH in mLTC by confocal microscope. Expression of fusion protein GRTH-EGFP or EGFP alone (control) in the living cells was examined by confocal microscope under a 40 × oil objective len. Green fluorescence signals from GRTH-EGFP with lower amplification (a, zoom = 2) and higher amplification (b, zoom = 5) and from EGFP (control) with higher amplification (c, zoom = 5) were recorded (bars = 10 µm). D, Western blot analysis. GRTH-GST and GST were revealed by a GFP antibody. Molecular mass values are indicated on the left.

Subcellular localization of transfected GRTH tagged with the enhanced green fluorescence protein (GRTH-EGFP) in mLTC cells by confocal microscopy illustrated that GRTH-EGFP was present predominantly in the cytoplasm (Fig. 6C, a and b), whereas EGFP (control) was present throughout the nucleus, membrane, and cytoplasm (Fig. 6C, c). It could not be excluded completely the presence of GRTH-EFGP in the nucleus since vestigial fluorescence was observed in some transfected cells. The specificity of GRTH-EGFP expression was assessed by Western blot using an anti-GFP monoclonal antibody (Fig. 6D). A single band of 69 kDa which corresponded to the GRTH-EGFP fusion protein (42 kDa, GRTH; 27 kDa, EFGP) was observed in cells transfected with GRTH-EGFP, whereas a band of 27 kDa was observed in EFGP-transfected cells. No bands were detected in the negative control cells.

Purified Recombinant GRTH Displayed ATPase and RNA Helicase Activity-- The purified recombinant GRTH-GST fusion protein (71 kDa) and recombinant GST (29 kDa) resolved as single bands on stained SDS-PAGE (Fig. 7A, left) were utilized to assess the function of GRTH. Western blots displayed single immunostained bands that migrated at positions that corresponded to the stained bands (Fig. 7A, right). Whereas the purified GST used as control showed no ATP hydrolyzing activity (Fig. 7B), the GRTH-GST displayed significant ATPase activity, which was further stimulated 3-fold by the addition of mRNA and poly(A) nucleotides. Addition of poly(U), total RNA, and tRNA only increased the activity by 20-40%, whereas DNA caused a 2.5-fold increase in activity. Omission of MgCl2 or addition of EDTA in the reaction completely abolished the activity (data not shown). These results demonstrated that GRTH possessed intrinsic ATPase activity with an absolute requirement for Mg2+ and that RNA and DNA increase the ATP hydrolyzing activity of GRTH.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 7.   Recombinant GRTH (A) for use in GRTH ATPase (B) and helicase assays (C). A, purified recombinant GRTH-GST fusion protein or GST alone: left, colloidal staining of SDS-PAGE; right, immunostaining of blot with GST antibody. B, ATPase assays: ATP hydrolyzed by GRTH-GST or GST (control) in the absence (-) and presence of mRNA, poly(A), poly(U), total RNA, tRNA, and DNA. C, helicase assays were performed by incubation of 0.2 pmol of substrates with GRTH-GST or GST at 37 °C for 30 min. Structure and length (bp) of RNA or DNA substrates are indicated schematically. Short strands of RNA or DNA were labeled by [32P]ATP. Double-stranded (ds) substrates incubated without protein at 37 °C or heated at 100 °C were used as negative or positive controls, respectively. Ss, single-stranded nucleotides.

To evaluate the RNA helicase activity of GRTH, we synthesized different duplexes of RNA/RNA, RNA/DNA, and DNA/DNA as substrates (Fig. 7C, upper panels) and incubated with purified GRTH-GST or GST (control). A single stretch of at least 30 bp at both 5'- and 3'-ends of RNA or DNA was provided for the binding of GRTH-GST protein. The double strands of RNA/RNA and RNA/DNA were unwound by GRTH-GST in a dose-dependent manner (0.1-1.0 µg), whereas the GST (negative control) did not show activity (Fig. 7C). Omission of ATP from the reaction abolished GRTH unwinding activity. In contrast, double-stranded DNA could not be unwound by GRTH-GST. Duplex substrates with a 5'- or 3'-single-stranded RNA tail (provided as an unwinding initiation site) were utilized to determine the directionality of unwinding induced by GRTH. GRTH-GST catalytically unwound both 3'- and 5'-duplexes in a dose-dependent manner with the requirement of ATP, whereas GST controls were inactive. These results demonstrate that GRTH is an ATP-dependent bidirectional RNA helicase.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this study, we have cloned and characterized a novel gonadotropin-regulated and developmentally expressed testicular RNA helicase (GRTH). This protein, which is expressed in the Leydig and germ cells of the testis, belongs to the DEAD (Asp-Glu-Ala-Asp)-box family within the superfamily of RNA helicases (28) and contains all the conserved domains of the family. GRTH differs from other members of this family in having high intrinsic ATPase activity in the absence of RNA but resembles several members (19, 21, 27), in that its ATPase activity was remarkably enhanced in presence of mRNA, synthetic poly(A), and DNA. Thus, GRTH not only catalyzed ATP hydrolysis to supply energy for RNA processes but perhaps also for some other biological processes. The DNA-enhanced ATP hydrolysis is not utilized for the process of unwinding DNA duplexes. Bidirectional unwinding of RNA duplexes suggested that GRTH is not only a less restricting ATPase and but also a less restricting RNA helicase. These functional features indicate that GRTH could be involved in a variety of biological processes in the target tissues. It is very likely that GRTH participates in poly(A)+-related mRNA processes including melting the secondary structure of mRNA and initiation of translation.

GRTH is the first protein of the DEAD-box family reported to be regulated by a hormone. The initial goal of the study was to identify factor(s) responsible for gonadotropin down-regulation of gonadal receptors and steroidogenic enzymes of testicular Leydig cells that would consequently reflect the production of androgen. On the other hand, for maintenance of the expression of relevant and/or general cellular genes and the restoration of the cellular down-regulated functions, some activators may be induced or enhanced during the initial hormonal stimulus or early in the desensitization process. GRTH was the only displayed fragment that was verified as an hCG up-regulated gene. However, the regulation of GRTH increase by hCG did not precede the reduction of these enzymes (2-5). This suggested that GRTH does not play a role in the down-regulation phase of the desensitizing process but perhaps in other gonadotropin-regulated cellular functions, including maintenance of steroidogenic enzymes and receptors and their recovery from desensitization. In this regard, the return of GRTH expression to control correlated with the temporal recovery of enzymes and receptors (3-5).

We also demonstrated that the up-regulation of GRTH gene expression results from direct and/or indirect actions at the transcriptional level of signaling molecules or metabolic products induced by hCG. The regulation of GRTH could share aspects of the control mechanism(s) responsible for hCG-induced down-regulation of steroidogenic enzymes and receptors. Our cotransfection studies excluded the involvement of GRTH as a transcriptional inhibitor responsible for hCG-induced desensitization of receptors and steroidogenic enzymes (Fig. 6A). The similar GRTH-induced increases of reporter gene activities driven by different promoters in the absence of mRNA changes implied that the stimulating action of GRTH was through a common mechanism at the post-transcriptional level. The increased in vitro translational activity induced by GRTH and the predominant localization of GRTH-GFP in the cytoplasm of transfected cells (Fig. 6, B and C) support its involvement in the translational process. However, its participation in other biological processes cannot be excluded, since weak nuclear localization was observed, and both RNA and DNA can stimulate ATPase activity of GRTH. Thus, it is conceivable that the up-regulation of the GRTH gene product induced by the hormonal stimuli may contribute to the translatability of hormone receptors and steroidogenic enzymes and other proteins.

GRTH is specifically expressed in male but not in female gonadal tissue. In addition to its expression in the Leydig cells of the interstitial compartment of the testis, GRTH is also highly expressed in meiotic and round haploid germinal cells (Fig. 3). Differentiation in germ cells requires enhanced activation of transcription and translation of specific genes in which GRTH may play important roles. Interestingly, some members of the RNA helicase family were expressed differentially during development or restrictively distributed in germ cells (24-26, 29), and it has been suggested that these proteins may actively participate in sexual development (25) and in the process of oogenesis (24, 29) and spermatogenesis (26). The structure and function of GRTH links this new helicase with other members of the RNA helicase family, including eIF4A (22, 30), Ded1p (31), and PL10 proteins (26).

The male gonad-specific expression of GRTH and the striking increase of its mRNA in pubertal and post-pubertal rodents suggest that GRTH is functionally related to gonadal maturation and spermatogenesis. The developmental increase in GRTH in the pubertal rodent testis occurs at the same time as gonadotropin-induced androgen responses appear in the Leydig cell (32), and when the differentiation of germ cells that ultimately leads to the development of haploid spermatids begins to occur (33). It is reasonable to propose that the steroid hormone produced in the gonadotropin-stimulated testis could not only exert intracrine or autocrine actions on GRTH gene expression in the Leydig cell but may also influence GRTH gene transcription within the seminiferous tubule. The notably high expression of the helicase in pachytene spermatocytes indicates that GRTH may be one of the genes involved in the meiotic process that has a crucial role in spermatogenesis (34).

The specific expression of GRTH in the testis, but not in ovary, implies that its gene is either suppressed by female-specific or induced by male-specific gonadal factor(s). Since estrogen is produced in both male and female gonads, it is unlikely to be involved in the induction of GRTH gene expression. Consistent with this, estradiol did not affect GRTH mRNA in cultured rat Leydig cells. In contrast, the non-metabolizable androgen, dihydrotestosterone, increased the expression of GRTH mRNA in Leydig cells. The stimulation effects of hCG in vivo on the GRTH gene expression were also observed in vitro, and cAMP, the second messenger of hCG action, had comparable effects. However, no stimulation was observed after inhibition of steroid biosynthetic enzymes, which abolished hCG- and cAMP-stimulated increases of testosterone in Leydig cells. The absence of a rapid change in basal GRTH mRNA levels during androgen suppression in vitro is not unexpected, since incubations could only be conducted with short term primary cultures and the GRTH mRNA is long-lived (Fig. 4C). Androgen induced by gonadotropin could act through its cognate receptors in the Leydig cell to increase GRTH gene expression. It could also exert actions in the germinal cells of the seminiferous epithelium through androgen receptors present in Sertoli cells, since germinal cells do not possess androgen receptors (35). Although androgens are not present in the pituitary, hypothalamus, and brain, where low GRTH mRNA levels are found, androgen receptors are present in these tissues. It is conceivable that androgen from the circulation may induce GRTH expression at these sites. Major developmental changes in GRTH mRNA were observed during puberty when predominant expression of GRTH mRNA was observed in the Leydig cell and germinal epithelium. Our findings suggest that this novel testicular helicase could serve to maintain testicular functions related to steroidogenesis and spermatogenesis.

    ACKNOWLEDGEMENT

We are grateful to Dr. Kenneth S. K. Tung (Department of Pathology, University of Virginia Medical School, Charlottesville, VA) for valuable advice on histological interpretation.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF142629, AF142630, AF155140.

Dagger To whom correspondence should be addressed: Bldg. 49, Rm. 6A36, 49 Convent Dr. MSC4510, National Institutes of Health, Bethesda, MD 20892-4510. Tel.: 301-496-2021: Fax: 301-480-8010: E-mail: dufau@helix.nih.gov.

    ABBREVIATIONS

The abbreviations used are: LH, luteinizing hormone; hCG, human chorionic gonadotropin; GRTH, gonadotropin-regulated testicular RNA helicase; PCR, polymerase chain reaction; FISH, fluorescence in situ hybridization; bp, base pair; GST, glutathione S-transferase; PAGE, polyacrylamide gel electrophoresis; BSA, bovine serum albumin; kb, kilobase pairs; nt, nucleotide EGFP, enhanced green fluorescence protein; GFP, green fluorescence protein.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Dufau, M. L. (1988) Annu. Rev. Physiol. 50, 483-508[CrossRef][Medline] [Order article via Infotrieve]
2. Dufau, M. L., Cigorraga, S. B., Baukal, A. J., Bator, J. M., Sorrell, S. H., Neubauer, J. F., and Catt, K. J. (1979) J. Steroid Biochem. 11, 193-199[CrossRef][Medline] [Order article via Infotrieve]
3. Tang, P. Z., Tsai-Morris, C. H., and Dufau, M. L. (1998) Endocrinology 139, 4496-4505[Abstract/Free Full Text]
4. Tsai-Morris, C. H., Khanum, A., Tang, P.-Z., and Dufau, M. L. (1999) Endocrinology 140, 3534-3542[Abstract/Free Full Text]
5. Nishihara, M., Winters, C. A., Buzko, E., Waterman, M. R., and Dufau, M. L. (1988) Biochem. Biophys. Res. Commun. 154, 151-158[CrossRef][Medline] [Order article via Infotrieve]
6. Dufau, M. L., and Catt, K. J. (1978) Vitam. Horm. 36, 461-592[Medline] [Order article via Infotrieve]
7. Nozu, K., Dehejia, A., Zawistowich, L., Catt, K. J., and Dufau, M. L. (1981) J. Biol. Chem. 256, 12875-12882[Free Full Text]
8. Nozu, K., Matsuura, S., Catt, K. J., and Dufau, M. L. (1981) J. Biol. Chem. 256, 10012-10017[Free Full Text]
9. Aquilano, D. R., and Dufau, M. L. (1984) Endocrinology 114, 499-510[Abstract/Free Full Text]
10. Cigorraga, S. B., Dufau, M. L., and Catt, K. J. (1978) J. Biol. Chem. 253, 4297-4304[Free Full Text]
11. Aquilano, D. R., Tsai-Morris, C. H., Hattori, M. A., and Dufau, M. L. (1985) Endocrinology 116, 1745-1754[Abstract/Free Full Text]
12. Khanum, A., Buczko, E., and Dufau, M. L. (1997) Endocrinology 138, 1612-1620[Abstract/Free Full Text]
13. Liang, P., and Pardee, A. B. (1992) Science 257, 967-971[Abstract/Free Full Text]
14. Gilman, M. (1987) in Current Protocols in Molecular Biology (Ausubel, F. M. , Brent, R. , Kingston, R. E. , Moore, D. D. , Seidman, J. G. , Smith, J. A. , and Struhl, K., eds) , pp. 4.7.1-4.7.8, Greene Publishing Associates and Wiley-Interscience, New York
15. Heng, H. H., Squire, J., and Tsui, L. C. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9509-9513[Abstract/Free Full Text]
16. Greenberg, M. E., and Bender, T. P. (1990) in Current Protocols in Molecular Biology (Ausubel, F. M. , Brent, R. , Kingston, R. E. , Moore, D. D. , Seidman, J. G. , Smith, J. A. , and Struhl, K., eds) , pp. 4.10.1-4.10.9, Greene Publishing Associates and Wiley-Interscience, New York
17. Fox, C. H., and Cottler-Fox, M. (1993) in Current Protocols in Immunology (Coligan, J. , and Kruisbeek, A., eds) , pp. 2.8.1-2.8.21, John Wiley & Sons, Inc., New York
18. Merrick, W. C., and Sonenberg, N. (1997) Methods 11, 333-342[CrossRef][Medline] [Order article via Infotrieve]
19. Pause, A., and Sonenberg, N. (1992) EMBO J. 11, 2643-2654[Medline] [Order article via Infotrieve]
20. Gee, S. L., and Conboy, J. G. (1994) Gene (Amst.) 140, 171-177[CrossRef][Medline] [Order article via Infotrieve]
21. Tseng, S. S., Weaver, P. L., Liu, Y., Hitomi, M., Tartakoff, A. M., and Chang, T. H. (1998) EMBO J. 17, 2651-2662[CrossRef][Medline] [Order article via Infotrieve]
22. Jaramillo, M., Dever, T. E., Merrick, W. C., and Sonenberg, N. (1991) Mol. Cell. Biol. 11, 5992-5997[Abstract/Free Full Text]
23. Lu, D., and Yunis, J. J. (1992) Nucleic Acids Res. 20, 1967-1972[Abstract/Free Full Text]
24. de Valoir, T., Tucker, M. A., Belikoff, E. J., Camp, L. A., Bolduc, C., and Beckingham, K. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 2113-2117[Abstract/Free Full Text]
25. Maekawa, H., Nakagawa, T., Uno, Y., Kitamura, K., and Shimoda, C. (1994) Mol. Gen. Genet. 244, 456-464[CrossRef][Medline] [Order article via Infotrieve]
26. Leroy, P., Alzari, P., Sassoon, D., Wolgemuth, D., and Fellous, M. (1989) Cell 57, 549-559[CrossRef][Medline] [Order article via Infotrieve]
27. Hirling, H., Scheffner, M., Restle, T., and Stahl, H. (1989) Nature 339, 562-564[CrossRef][Medline] [Order article via Infotrieve]
28. Schmid, S. R., and Linder, P. (1992) Mol. Microbiol. 6, 283-291[Medline] [Order article via Infotrieve]
29. Gururajan, R., Perry, O. K. H., Melton, D. A., and Weeks, D. L (1991) Nature 349, 717-719[CrossRef][Medline] [Order article via Infotrieve]
30. Rozen, F., Edery, I., Meerovitch, K., Dever, T. E., Merrick, W. C., and Sonenberg, N. (1990) Mol. Cell. Biol. 10, 1134-1144[Abstract/Free Full Text]
31. Chuang, R. Y., Weaver, P. L., Liu, Z., and Chang, T. H. (1997) Science 275, 1468-1471[Abstract/Free Full Text]
32. Huhtaniemi, I. T., Nozu, K., Warren, D. W., Dufau, M. L., and Catt, K. J. (1982) Endocrinology 111, 1711-1720[Abstract/Free Full Text]
33. Clermont, Y., and Perey, B. (1957) Am. J. Anat. 100, 241-268[CrossRef][Medline] [Order article via Infotrieve]
34. Edelmann, W., Cohen, P. E., Kane, M., Lau, K., Morrow, B., Bennett, S., Umar, A., Kunkel, T., Cattoretti, G., Chaganti, R., Pollard, J. W., Kolodner, R. D., and Kucherlapati, R. (1996) Cell 85, 1125-1134[CrossRef][Medline] [Order article via Infotrieve]
35. Bremner, W. J., Millar, M. R., Sharpe, R. M., and Saunders, P. T. (1994) Endocrinology 135, 1227-1234[Abstract]
36. Tsai-Morris, C. H., Geng, Y., Xie, X. Z., Buczko, E., and Dufau, M. L. (1994) J. Biol. Chem. 269, 15868-15875[Abstract/Free Full Text]
37. Tsai-Morris, C. H., Geng, Y., Buczko, E., and Dufau, M. L. (1998) J. Clin. Endocrinol. & Metab. 83, 288-291[Abstract/Free Full Text]
38. Hu, Z., Zhuang, L., Guan, X., Meng, J., and Dufau, M. L. (1997) J. Biol. Chem. 272, 14263-14271[Abstract/Free Full Text]
39. Dufau, M. L., Miyagawa, Y., Takada, S., Khanum, A., Miyagawa, H., and Buczko, E. (1997) Steroids 62, 128-132[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
C.-H. Tsai-Morris, E. Koh, and M. L. Dufau
Differences in gonadotropin-regulated testicular helicase (GRTH/DDX25) single nucleotide polymorphism between Japanese and Chinese populations
Hum. Reprod., November 1, 2008; 23(11): 2611 - 2613.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. K. Gutti, C.-H. Tsai-Morris, and M. L. Dufau
Gonadotropin-regulated Testicular Helicase (DDX25), an Essential Regulator of Spermatogenesis, Prevents Testicular Germ Cell Apoptosis
J. Biol. Chem., June 20, 2008; 283(25): 17055 - 17064.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
C.-H. Tsai-Morris, E. Koh, Y. Sheng, Y. Maeda, R. Gutti, M. Namiki, and M. L. Dufau
Polymorphism of the GRTH/DDX25 gene in normal and infertile Japanese men: a missense mutation associated with loss of GRTH phosphorylation
Mol. Hum. Reprod., December 1, 2007; 13(12): 887 - 892.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Sheng, C.-H. Tsai-Morris, R. Gutti, Y. Maeda, and M. L. Dufau
Gonadotropin-regulated Testicular RNA Helicase (GRTH/Ddx25) Is a Transport Protein Involved in Gene-specific mRNA Export and Protein Translation during Spermatogenesis
J. Biol. Chem., November 17, 2006; 281(46): 35048 - 35056.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. Linder
Dead-box proteins: a family affair--active and passive players in RNP-remodeling
Nucleic Acids Res., September 10, 2006; 34(15): 4168 - 4180.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Z. A, S. Zhang, Y. Yang, Y. Ma, L. Lin, and W. Zhang
Single nucleotide polymorphisms of the gonadotrophin-regulated testicular helicase (GRTH) gene may be associated with the human spermatogenesis impairment
Hum. Reprod., March 1, 2006; 21(3): 755 - 759.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-H. Tsai-Morris, Y. Sheng, E. Lee, K.-J. Lei, and M. L. Dufau
Gonadotropin-regulated testicular RNA helicase (GRTH/Ddx25) is essential for spermatid development and completion of spermatogenesis
PNAS, April 27, 2004; 101(17): 6373 - 6378.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Sheng, C.-H. Tsai-Morris, and M. L. Dufau
Cell-specific and Hormone-regulated Expression of Gonadotropin-regulated Testicular RNA Helicase Gene (GRTH/Ddx25) Resulting from Alternative Utilization of Translation Initiation Codons in the Rat Testis
J. Biol. Chem., July 18, 2003; 278(30): 27796 - 27803.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
M. D. Anway, Y. Li, N. Ravindranath, M. Dym, and M. D. Griswold
Expression of Testicular Germ Cell Genes Identified by Differential Display Analysis
J Androl, March 1, 2003; 24(2): 173 - 184.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Yan, J.-F. Mouillet, Q. Ou, and Y. Sadovsky
A Novel Domain within the DEAD-Box Protein DP103 Is Essential for Transcriptional Repression and Helicase Activity
Mol. Cell. Biol., January 1, 2003; 23(1): 414 - 423.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
P.-Z. Tang, C.-H. Tsai-Morris, and M. L. Dufau
Cloning and characterization of a hormonally regulated rat long chain acyl-CoA synthetase
PNAS, May 24, 2001; (2001) 121046998.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P.-Z. Tang, C.-H. Tsai-Morris, and M. L. Dufau
Cloning and characterization of a hormonally regulated rat long chain acyl-CoA synthetase
PNAS, June 5, 2001; 98(12): 6581 - 6586.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tang, P.-Z.
Right arrow Articles by Dufau, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, P.-Z.
Right arrow Articles by Dufau, M. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement